Claris sells global generic injectables business to Baxter for $625 mn

AHMEDABAD, JULY 28:   City-based pharma player, Claris Lifesciences Ltd, said the company has completed the sale of its Global Generic Injectables Business to Baxter International Inc (USA) for an enterprise value of $625 million. The company will discuss with its advisors and identify the most efficient method of transferring a significant majority of the net proceeds to […]